Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • luoruicd
    Junior Member
    • Oct 2010
    • 4

    #1

    An estimation of coverage

    Hi All,
    I am very new for the sequencing world. To be honest, I haven't touched any sequencing data yet. So forgive me if my question is trivial.
    I plan to run RNA-seq for 5 human samples in one lane on Illumina GA IIx. Now it could provide 40 million reads per lane. I order the 100bp pair-end reads.
    So I am considering to estimate the coverage like how my experiment covers the low expressed genes, I did an estimation like this:
    Now for each samples, it covers
    8 X10^6 reads, so 8X10^8 base pair
    Assume that the average gene length for human genome is 1000 bp, and the for each base pair, the coverage of 10 would be enough to make sure it's real, so for each gene we need 10^4 base pairs to make it sure;
    1/(8X10^6/10^4)~ 0.001%, so it means for gene whose expression abundance ~0.001% of the whole transcriptome, we can detect it.
    Since I have to write a proposal, I have think of a way to estimate it, can you tell me whether this is totally wrong or it's ok to think this way, but the number should be modified?

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2





    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification,...
    10-30-2026, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 07:59 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 11-05-2026, 09:25 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 11-03-2026, 11:54 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
172 views
0 reactions
Last Post SEQadmin2  
Working...